Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Sabra Health Care REIT (SBRA) · oqro.io/stocks/SBRA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Questions about Sabra Health Care REIT insider trading
Have Sabra Health Care REIT insiders bought shares recently?
No open-market purchase by an insider of Sabra Health Care REIT was filed in the last 90 days. The latest on record was on Feb 25, 2025.
How often do Sabra Health Care REIT insiders buy and sell shares?
Since 2011, Sabra Health Care REIT insiders reported 53 open-market purchases and 18 sales on Forms 4 and 5, with purchases in 9 different years, most recently 2025.
Who is selling Sabra Health Care REIT stock?
In the last 90 days, 2 insiders of Sabra Health Care REIT (SBRA) reported 2 open-market sales worth $4.38M in total on SEC Form 4. The largest seller by value was Richard K Matros, with $4.17M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Do members of Congress trade SBRA?
No trade in Sabra Health Care REIT (SBRA) was disclosed by a member of Congress in the last 12 months.
When does Sabra Health Care REIT report its next results?
Sabra Health Care REIT's next results are expected on Feb 10, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
SBRA price and disclosed activity
+9.9% (+$1.84) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $18.55 on Nov 20, 2025 to $20.39 on Nov 20, 2026 (+9.9%). Disclosed in this range: 1 insider trade, 2 pre-arranged insider sales, 0 Congress trades, and 16 13F position changes for 3 quarters ending in it.
$17$18$19$21$22$23$20.39
DecJan 2026FebMarAprMayJunJulAugSepOctNov
13F holdings, by quarter end
Insider and Congress marks sit on the trade date stated in the filing; solid is a purchase, hollow a sale. A number means several trades too close to tell apart at this range: pick a shorter range or open it for the list. Fund 13F reports are quarter-end snapshots filed up to 45 days later, so they are shown under the chart across the quarter they describe, not on the price line. Congress amounts are official ranges; mark size uses the lower bound. Past moves are not a forecast.Show the 3 trades in this range as a list
Michael J Foster, Director · Pre-arranged insider sale, about $210Ktraded Nov 11, 2026, filed Nov 12, 2026
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care REITs company.
Last 12 months
+9.9%
S&P 500 +5.7% over the same dates
Market value
$5.34B
Close of Nov 20, 2026 × shares outstanding (per ADS where it applies)
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 17.9M shares sold short (6.8% of shares outstanding), +0.9% vs the previous count, 8.3 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
13 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
12 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 13, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Red flags in its filings
Jan 5
Top officer leaving
“Nevo-Hacohen’s retirement, Michael Costa was appointed by the Board to serve as the Company’s Treasurer (in addition to continuing to serve as the Company’s Executive Vice President and Chief Financial Officer) effective January 1, 2026, until his successor is duly elected and qualifies.”
From the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Insider buying and selling since 2011
Insiders of Sabra Health Care REIT reported 53 open-market purchases and 18 sales since 2011; purchases in 9 different years, most recently 2025.
Year
Bought
Sold
2026
—
$4.68M3×3 trades
2025
$40K2×2 trades
$200K1×1 trade
2024
$101K1×1 trade
$147K1×1 trade
2023
$25K1×1 trade
—
2022
$26K1×1 trade
—
2021
$52K2×2 trades
$1.6M3×3 trades
2020
$99K2×2 trades
$194K1×1 trade
2019
—
$4.27M3×3 trades
2018
—
$10K1×1 trade
2017
—
$89K1×1 trade
2016
—
$44K1×1 trade
2015
$633K8×8 trades
$131K2×2 trades
2013
$402K6×6 trades
$83K1×1 trade
2011
$413K30×30 trades
—
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Latest results: quarter ending Sep 30, 2026
Revenue
$250M
+31.3% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
$2.4B
Debt $2.44B, cash $36.2M, at Sep 30, 2026
Net income, last 12 months
$71.5M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 2, 2026.
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 11,000 words.
From “Overview”, in the company's words
We expect to grow our investment portfolio while diversifying our portfolio by tenant, facility type and geography within the healthcare sector. We plan to achieve these objectives primarily through making investments directly or indirectly in healthcare real estate, including the development of purpose-built healthcare facilities with select developers. We also intend to achieve our objective of diversifying our portfolio by tenant and facility type through select asset sales and other arrangements with our tenants.
What the section covers (40 headings)
Overview
Market Trends and Uncertainties
Acquisitions
Dispositions
Senior Unsecured Notes
Term Loan Credit Facility
At-The-Market Common Stock Offering Program
Critical Accounting Policies and Estimates
Variable Interest Entities
Real Estate Investments and Rental Revenue Recognition
Real Estate Acquisition Valuation
Impairment of Real Estate Investments
Revenue Recognition
Investment in Unconsolidated Joint Ventures
And 26 more headings in the filing.
Source: SEC EDGAR, Form 10-K filed Feb 12, 2026. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
Off-exchange trading: 37.5% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (19.1% on ATS, 18.4% with other brokers), close to its 26-week average of 38.7%. Weeks of Sep 21 to Oct 16, 2026.
Week of Apr 20ATSOther off-exchangeFull height = all shares tradedWeek of Oct 12
Largest ATS: INTELLIGENT CROSS LLC (17.1%), LEVEL ATS (10.7%), MS TRAJECTORY CROSS (ATS-1) (8.9%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
When insiders usually buy
Last results
Nov 2, 2026
Within the 30 days after it, until Dec 2, 2026
Next results, expected
Feb 10, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
Not enough history
From Sabra Health Care REIT's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Sabra Health Care REIT's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Owners above 5%
No Schedule 13D or 13G filing on SBRA over the last three years: no investor has reported crossing 5% of its stock in that time.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Risk factors in the annual report
Latest annual report filed Feb 12, 2026, compared with the one filed Feb 19, 2025. Read the filing
New risk factors in the latest annual report (1 heading)
Changes in federal, state, or local laws limiting REIT investments in the health care sector may adversely impact our ability to participate in the ownership of and investment in health care real estate.
No longer listed (1 heading from the year before)
Our reported rental and related revenues may be subject to increased variability as a result of ASU 2016-02, Leases, as amended by subsequent ASUs (“Topic 842”).
Legal proceedings (Item 3)
For a description of our legal proceedings, see Note 16, “Commitments and Contingencies—Legal Matters” in the Notes to Consolidated Financial Statements included in this 10-K, which is incorporated by reference in response to this item.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 12, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
OQRO Intelligence
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Insiders. In the 12 months to Nov 19, 2026, insiders of Sabra Health Care REIT filed 0 open-market purchases (about $0, in 0 filings, by 0 people) and 3 open-market sales (about $4.68M, in 3 filings, by 3 people). One Form 4 can list many transactions. In the 12 months before that, they filed 2 open-market purchases (about $40K, in 1 filing) and 1 open-market sale (about $200K, in 1 filing). (Sabra Health Care REIT on OQRO)
Funds and stakes. Fund 13F filings recorded in the 12 months show 10 new or larger positions and 6 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Contracts, lobbying and filings. FINRA short interest for SBRA on the settlement date of Oct 30, 2026 was 17,882,953 shares (+0.93% on the previous report), about 8.26 days of average volume. In 13F filings for the quarter ended Jun 30, 2026, the largest positions that grew: Centersquare Investment Management LLC (increased, 1,936,617 shares); Duff & Phelps Investment Management Co (increased, 503,171 shares); the largest that shrank: Ontario Teachers Pension Plan Board (sold out); Bailard, Inc. (sold out). A 13F is a quarter-end snapshot with no trade date.
Company reports, price and press. Sabra Health Care REIT filed a Form 8-K on Nov 2, 2026 (Items 2.02, 7.01) that OQRO classes as: reported its results, and shared information with investors. Sabra Health Care REIT filed a Form 8-K on Aug 3, 2026 (Items 2.02, 7.01) that OQRO classes as: reported its results, and shared information with investors.
Who holds it. 463 funds reported a stake in Sabra Health Care REIT in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (15.9% of the value reported), PRINCIPAL FINANCIAL GROUP INC (9.5% of the value reported), VANGUARD PORTFOLIO MANAGEMENT LLC (8.9% of the value reported).
Things to keep in mind. These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why. A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade. Total compensation in a proxy statement counts stock and option awards at their grant-date value, not what was sold.
Facts used for this text
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
In the 12 months to Nov 19, 2026, insiders of Sabra Health Care REIT filed 0 open-market purchases (about $0, in 0 filings, by 0 people) and 3 open-market sales (about $4.68M, in 3 filings, by 3 people). One Form 4 can list many transactions.
In the 12 months before that, they filed 2 open-market purchases (about $40K, in 1 filing) and 1 open-market sale (about $200K, in 1 filing).
The largest sale: Richard K Matros, Chair, CEO and President, about $4.17M, filed Sep 9, 2026.
Funds and stakes
Fund 13F filings recorded in the 12 months show 10 new or larger positions and 6 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Contracts, lobbying and filings
FINRA short interest for SBRA on the settlement date of Oct 30, 2026 was 17,882,953 shares (+0.93% on the previous report), about 8.26 days of average volume.
In 13F filings for the quarter ended Jun 30, 2026, the largest positions that grew: Centersquare Investment Management LLC (increased, 1,936,617 shares); Duff & Phelps Investment Management Co (increased, 503,171 shares); the largest that shrank: Ontario Teachers Pension Plan Board (sold out); Bailard, Inc. (sold out). A 13F is a quarter-end snapshot with no trade date.
For fiscal 2025, the company's proxy statement reported total compensation of $8.55M for its principal executive officer, and an average of $2.84M for the other named executive officers.
Company reports, price and press
Sabra Health Care REIT filed a Form 8-K on Nov 2, 2026 (Items 2.02, 7.01) that OQRO classes as: reported its results, and shared information with investors.
Sabra Health Care REIT filed a Form 8-K on Aug 3, 2026 (Items 2.02, 7.01) that OQRO classes as: reported its results, and shared information with investors.
Sabra Health Care REIT filed a Form 8-K on Jan 5, 2026 (Items 5.02, 7.01) that OQRO classes as: changed a top executive or board member, and shared information with investors.
The company's own opening sentence of that report reads: "Overview As previously disclosed in a Form 8-K filed by Sabra Health Care REIT, Inc. ('Sabra' or the 'Company') on March 24, 2025 (the 'March 8-K'), Talya Nevo-Hacohen, the Company’s Chief Investment Officer, Treasurer and Execut..."
Press coverage listed by Finnhub: "PINE or SBRA: Which Is the Better Value Stock Right Now?" (Yahoo, Nov 18, 2026).
Press coverage listed by Finnhub: "Realty Income or Sabra Health Care REIT: I Can Only Pick One Dividend Stock for the Next 10 Years. Here’s Mine" (Yahoo, Nov 18, 2026).
Press coverage listed by Finnhub: "Sabra Health Care REIT Is A Buy After Q3 Shows More Portfolio Expansion" (SeekingAlpha, Nov 11, 2026).
SBRA closed at $20.62 on Nov 18, 2026, the last session on or before the end of the period.
From Oct 19, 2026 to Nov 18, 2026, the close moved from $19.08 to $20.62, a change of +8.1%.
Who holds it
463 funds reported a stake in Sabra Health Care REIT in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (15.9% of the value reported), PRINCIPAL FINANCIAL GROUP INC (9.5% of the value reported), VANGUARD PORTFOLIO MANAGEMENT LLC (8.9% of the value reported).
Things to keep in mind
These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why.
A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade.
Total compensation in a proxy statement counts stock and option awards at their grant-date value, not what was sold.
An 8-K item says what the company reported, not what it means for the share price.
Headlines are listed as published by the outlets; OQRO has not checked them and does not summarise articles.
Share price moves are listed as context only; the filing does not explain them and other news can move a price.
This describes public filings. It is not investment advice.
Since Nov 19, 2025, SBRA is up 9.6% and the index fund is up 4.1%: 5 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much SBRA moves
A usual day
±0.8%Half of the sessions moved less than this, half moved more.
Daily range (ATR 14)
2.4%How far the price usually travels in a session, the gap from the day before included. Wilder's 14-session average.
Largest one-day fall
−4.2%Jun 1, 2026
Largest one-day rise
+10.2%Jul 21, 2026
Deepest fall of the year
−16.7%From the close of May 14, 2026 to Jun 4, 2026.
Days of 5% or more
1Out of 252 sessions, in either direction.
Beta −0.1(1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).